SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-173882
Filing Date
2007-08-07
Accepted
2007-08-07 17:15:08
Documents
6
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 407131
2 SUBLEASE AGREEMENT, DATED JUNE 19, 2007, BETWEEN NPS PHARMACEUTICALS, INC dex101.htm EX-10.1 51745
3 PURCHASE AND SALE AGREEMENT, DATED JUNE 29, 2007 dex102.htm EX-10.2 78820
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9218
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9185
6 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 4897
  Complete submission text file 0001193125-07-173882.txt   562315
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 071032512
SIC: 2836 Biological Products, (No Diagnostic Substances)